{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n In the study on asbestos‐related squamous cell lung carcinoma (ARLC‐SCC)"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": ", a comprehensive analysis was performed to identify differentially expressed genes and candidate biomarkers associated with asbestos‐related lung cancer. Although the investigation detailed 1,333 differentially expressed genes and highlighted several key “cross‐talk” genes (such as EGFR, PRKX, PDGFB, PIK3R3, SLK, IGF1, CDC42, and PRKCA) that bridge multiple ARLC‐SCC‐specific pathways, the functional role of LOC642929 was not explicitly characterized in the reported analyses. As such, LOC642929 appears among the differentially expressed gene set without an assigned specific function in the context of the pathways examined. The available data suggest that while LOC642929 is part of the molecular landscape of ARLC‐SCC, its biological role remains undefined based on this study, emphasizing the need for further investigations to clarify whether it might contribute to disease mechanisms or serve as an ancillary biomarker.\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Jiang Du, Lin Zhang "}, {"type": "b", "children": [{"type": "t", "text": "Pathway deviation-based biomarker and multi-effect target identification in asbestos-related squamous cell carcinoma of the lung."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Med (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/ijmm.2017.2878"}], "href": "https://doi.org/10.3892/ijmm.2017.2878"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28204826"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28204826"}]}]}]}